日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinoma.

耗竭的 TIL 中的肿瘤反应性 TCR 揭示了肾细胞癌中癌症类型特异性的免疫图谱。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1729388
Komahashi Mitsuru, Horaguchi Shun, Tsuji Kayoko, Hoshino Daisuke, Kishida Takeshi, Usui Kimitsugu, Nakaigawa Noboru, Sato Shinya, Hamana Hiroshi, Kishi Hiroyuki, Wei Feifei, Mano Yasunobu, Kouro Taku, Uehara Shuichiro, Sasada Tetsuro
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer

胃癌患者网膜乳斑中免疫细胞的特征及临床意义

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1521278
Mano, Yasunobu; Igarashi, Yuka; Komori, Keisuke; Hashimoto, Itaru; Watanabe, Hayato; Takahashi, Kosuke; Kano, Kazuki; Fujikawa, Hirohito; Yamada, Takanobu; Himuro, Hidetomo; Kouro, Taku; Wei, Feifei; Tsuji, Kayoko; Horaguchi, Shun; Komahashi, Mitsuru; Oshima, Takashi; Sasada, Tetsuro
胃癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors

基于机器学习的对接受免疫检查点抑制剂治疗的非小细胞肺癌患者循环自身抗体动态和治疗结果的深入分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1666030
Wei, Feifei; Takeda, Hiroyuki; Azuma, Koichi; Nakahara, Yoshiro; Igarashi, Yuka; Murotani, Kenta; Saito, Haruhiro; Murakami, Shuji; Kondo, Tetsuro; Kouro, Taku; Himuro, Hidetomo; Tsuji, Kayoko; Komahashi, Mitsuru; Sawasaki, Tatsuya; Sasada, Tetsuro
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation

增强基于质谱的肿瘤免疫肽鉴定：利用HLA结合亲和力、脂肪族指数和保留时间偏差的机器学习过滤器

期刊:Computational and Structural Biotechnology Journal
影响因子:4.1
doi:10.1016/j.csbj.2024.01.023
Wei, Feifei; Kouro, Taku; Nakamura, Yuko; Ueda, Hiroki; Iiizumi, Susumu; Hasegawa, Kyoko; Asahina, Yuki; Kishida, Takeshi; Morinaga, Soichiro; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Mano, Yasunobu; Nakamura, Norihiro; Kawamura, Takeshi; Sasada, Tetsuro
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors

MMP1、IL-1β、sTNFR-1 和 IL-6 是接受免疫检查点抑制剂治疗的不可切除或转移性肾细胞癌患者的预后因素。

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-024-02477-4
Nagasaka, Hirotaka; Kishida, Takeshi; Kouro, Taku; Igarashi, Yuka; Takebe, Shinichi; Yamamoto, Shotaro; Kondo, Takuya; Koizumi, Mitsuyuki; Terao, Hideyuki; Suzuki, Takahisa; Nakaigawa, Noboru; Himuro, Hidetomo; Wei, Feifei; Sasada, Tetsuro
肿瘤
肿瘤免疫
多发性骨髓瘤
肾癌
IL-1β
细胞生物学
IL-6
免疫/内分泌
发表日期：2024
文献求助 收藏

Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures

基于循环细胞因子特征的机器学习在非小细胞肺癌免疫治疗结果预测中的应用

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-006788
Wei, Feifei; Azuma, Koichi; Nakahara, Yoshiro; Saito, Haruhiro; Matsuo, Norikazu; Tagami, Tomoyuki; Kouro, Taku; Igarashi, Yuka; Tokito, Takaaki; Kato, Terufumi; Kondo, Tetsuro; Murakami, Shuji; Usui, Ryo; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Murotani, Kenta; Ban, Tatsuma; Tamura, Tomohiko; Miyagi, Yohei; Sasada, Tetsuro
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.

免疫检查点抑制剂治疗的非小细胞肺癌患者血浆中可溶性PD-1和PD-L1的临床作用

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03464-w
Himuro Hidetomo, Nakahara Yoshiro, Igarashi Yuka, Kouro Taku, Higashijima Naoko, Matsuo Norikazu, Murakami Shuji, Wei Feifei, Horaguchi Shun, Tsuji Kayoko, Mano Yasunobu, Saito Haruhiro, Azuma Koichi, Sasada Tetsuro
细胞生物学
肺癌
Checkpoint
肿瘤免疫
发表日期：2023
文献求助 收藏

Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma

免疫介质作为尿路上皮癌抗PD-1抗体治疗的预测性生物标志物

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1269935
Shibata, Yosuke; Kishida, Takeshi; Kouro, Taku; Wei, Feifei; Igarashi, Yuka; Himuro, Hidetomo; Noguchi, Takeaki; Koizumi, Mitsuyuki; Suzuki, Takahisa; Osaka, Kimito; Saigusa, Yusuke; Sasada, Tetsuro
肿瘤
肿瘤免疫
PD-1
免疫/内分泌
发表日期：2023
文献求助 收藏

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors

在接受免疫检查点抑制剂治疗的非小细胞肺癌患者中，循环中的IL-6而非其循环信号成分sIL-6R和sgp130具有临床意义。

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2023.1324898
Nakahara, Yoshiro; Kouro, Taku; Motoyama, Satoru; Miura, Masatomo; Fujita, Kazuma; Igarashi, Yuka; Higashijima, Naoko; Matsuo, Norikazu; Himuro, Hidetomo; Wei, Feifei; Horaguchi, Shun; Tsuji, Kayoko; Mano, Yasunobu; Komahashi, Mitsuru; Saito, Haruhiro; Azuma, Koichi; Sasada, Tetsuro
肺癌
肿瘤
肿瘤免疫
信号转导
gp130
细胞生物学
IL-6
免疫/内分泌
发表日期：2023
文献求助 收藏

Exhaustion of CAR T cells: potential causes and solutions

CAR-T细胞耗竭：潜在原因及解决方案

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-022-03442-3
Kouro, Taku; Himuro, Hidetomo; Sasada, Tetsuro
细胞生物学
T细胞
T细胞
免疫/内分泌
发表日期：2022
文献求助 收藏